Latest California Healthline Stories
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
One insurer is turning the tables on drugmakers with what may be a new job category: a sales force for cost-effective medicine.
About 300 health care systems around the country have set up medical-legal partnerships to help patients who are dealing with legal problems that affect their health.
The state health insurance exchange has instructed its participating health plans to submit alternative proposals for premium hikes that would offset the potential loss of an important source of federal funding.
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
A 22-year old man from Orange County, Calif., alleges in a lawsuit that his health insurer stopped paying for a crucial — and expensive — immunotherapy drug, leading him to become seriously ill. Treatments for patients with similar conditions are increasingly denied or interrupted, experts and patient advocates say.
A new JAMA study examines how drug rebates can direct money to middlemen and force Medicare patients to cough up more money.
Prosecutors say hedge-fund traders made millions trading on information leaked from Medicare.
“It’s unconscionable that such a basic, security 101 flaw could still exist at a major health care provider,” says one cybersecurity expert.
KHN’s Mary Agnes Carey and Julie Rovner discuss some of the developments that shook up health news this week.